Acquisition Announced

Sanofi acquisition of Dynavax Technologies

US$2.2bn equity value

Announced 23 Dec 2025 · US$15.50 cash per share

Advisers

Dynavax Technologies

Target

Legal adviser

Samba Merger Sub

Acquirer

Legal adviser
Target
Dynavax Technologies
Acquirer
Samba Merger Sub
Target based in
United States
Buyer based in
France
Sector
Biotech
Tags
Biotech, Pharma

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.